Table 3.
Comparison of the side effects and their duration of the Sinopharm (Beijing): BBIBP-CorV (Vero cells) and CanSino: Ad5-nCoV vaccines.
| Sinopharm (Beijing): BBIBP-CorV (Vero Cells) | CanSino: Ad5-nCoV | χ2 | p | Overall | |
|---|---|---|---|---|---|
| Gender | |||||
| Female | 5 (33.3%) | 3 (60%) | 8 | ||
| Male | 10 (66.7%) | 2 (40%) | 12 | ||
| Age | 14.47 (1.46/12–16) | 14.80 (1.79/12–17) | 14.55 (1.50/12–17) | ||
| Local Side effects | |||||
| Pain at the injection site N (%)/duration of relief range | 10 (23%/6 ± 2.83 1–10) | 1 (2.33%/3) | 1.197 | 0.274 | 11 |
| Redness at the injection site | 2 (4.65%/4 ± 4.24 1–7) | 0 | 0.567 | 0.451 | 2 |
| Swelling at the injection site | 2 (4.65%/2 ± 1.41 1–3) | 0 | 0.567 | 0.451 | 2 |
| Systemic side effects | |||||
| Headache | 2 (4.65%/8 ± 2.83 6–10) | 1 (2.33%/5) | 0.253 | 0.615 | 3 |
| Dizziness | 1 (2.33%/10) | 2 (4.65%/5) | 3.744 | 0.053 | 3 |
| Fatigue | 9 (20.93%/6.11 ± 1.96 3–10) | 2 (4.65%/3 ± 2.83 1–5) | 0.09 | 0.764 | 11 |
| Nausea/vomiting | 1 (2.33%/7) | 0 | 0.28 | 0.597 | 1 |
| Decreased appetite | 8 (18.60%/6.13 + -2.10 3–10) | 2 (4.65%/5) | 0.018 | 0.893 | 10 |